KRSA financials
Korsana Biosciences (KRSA) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
KRSA income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $2.07M | – | -$4.97M | -$3.53M | -1.11 |
| 2024 | $2.00M | – | -$3.63M | -$3.06M | -1.21 |
| 2023 | $0.00 | – | -$12.95M | -$5.26M | -2.25 |
| 2022 | $297.00K | – | -$18.54M | -$44.08M | -20.28 |
| 2021 | $3.94M | – | -$55.20M | -$51.65M | -26.40 |
| 2020 | $2.30M | – | -$81.27M | -$77.80M | -51.20 |
- KRSA revenue was $2.07M in fiscal 2025, net income -$3.53M.
Updated 2026-11-11 15:53 UTC